D.M. Collins

502 total citations
19 papers, 387 citations indexed

About

D.M. Collins is a scholar working on Molecular Biology, Cell Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, D.M. Collins has authored 19 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 3 papers in Cell Biology and 1 paper in Cardiology and Cardiovascular Medicine. Recurrent topics in D.M. Collins's work include Pluripotent Stem Cells Research (12 papers), CRISPR and Genetic Engineering (11 papers) and Renal and related cancers (10 papers). D.M. Collins is often cited by papers focused on Pluripotent Stem Cells Research (12 papers), CRISPR and Genetic Engineering (11 papers) and Renal and related cancers (10 papers). D.M. Collins collaborates with scholars based in United Kingdom, Germany and India. D.M. Collins's co-authors include Miles D. Houslay, Elaine V. Hill, Hannah Murdoch, George S. Baillie, David J. Porteous, J. Kirsty Millar, Shaun Mackie, Graeme B. Bolger, Enno Klußmann and Ahmed Mohamed and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

D.M. Collins

19 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.M. Collins United Kingdom 8 342 73 57 44 38 19 387
Kok Long Ang United Kingdom 4 406 1.2× 73 1.0× 143 2.5× 13 0.3× 69 1.8× 4 442
Marion C. Hogg Ireland 12 391 1.1× 40 0.5× 57 1.0× 13 0.3× 64 1.7× 18 537
Karina Formoso Argentina 12 213 0.6× 12 0.2× 46 0.8× 62 1.4× 36 0.9× 18 345
Clive Morris United Kingdom 11 290 0.8× 20 0.3× 42 0.7× 53 1.2× 23 0.6× 16 382
Sara C. Domingues Portugal 13 242 0.7× 23 0.3× 41 0.7× 93 2.1× 15 0.4× 14 355
Ashley J. Evans United Kingdom 10 218 0.6× 34 0.5× 109 1.9× 87 2.0× 8 0.2× 12 305
Jeffrey Adam Jamison United States 6 317 0.9× 24 0.3× 62 1.1× 36 0.8× 6 0.2× 11 499
Christopher P Webster United Kingdom 10 221 0.6× 43 0.6× 96 1.7× 90 2.0× 9 0.2× 12 579
Rebekah G. Langston United States 12 200 0.6× 17 0.2× 96 1.7× 54 1.2× 9 0.2× 20 471
Enhua Wang China 11 262 0.8× 21 0.3× 37 0.6× 23 0.5× 6 0.2× 29 391

Countries citing papers authored by D.M. Collins

Since Specialization
Citations

This map shows the geographic impact of D.M. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.M. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.M. Collins more than expected).

Fields of papers citing papers by D.M. Collins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.M. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.M. Collins. The network helps show where D.M. Collins may publish in the future.

Co-authorship network of co-authors of D.M. Collins

This figure shows the co-authorship network connecting the top 25 collaborators of D.M. Collins. A scholar is included among the top collaborators of D.M. Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.M. Collins. D.M. Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Collins, D.M., David Barneda, Karen E. Anderson, et al.. (2024). CDS2 expression regulates de novo phosphatidic acid synthesis. Biochemical Journal. 481(20). 1449–1473. 1 indexed citations
2.
Barneda, David, Izabella Niewczas, D.M. Collins, et al.. (2022). Acyl chain selection couples the consumption and synthesis of phosphoinositides. The EMBO Journal. 41(18). e110038–e110038. 17 indexed citations
3.
Anderson, Karen E., Sabine Suire, D.M. Collins, et al.. (2020). Gβγ is a direct regulator of endogenous p101/p110γ and p84/p110γ PI3Kγ complexes in mouse neutrophils. Science Signaling. 13(656). 16 indexed citations
4.
Sousa, Paul A. De, et al.. (2016). Derivation of the human embryonic stem cell line RCe009-A (RC-5). Stem Cell Research. 16(2). 418–422. 1 indexed citations
5.
Sousa, Paul A. De, et al.. (2016). Derivation of the human embryonic stem cell line RCe010-A (RC-6). Stem Cell Research. 16(2). 481–484. 1 indexed citations
6.
Sousa, Paul A. De, K. Bruce, D.M. Collins, et al.. (2016). Derivation of the clinical grade human embryonic stem cell line RCe021-A (RC-17). Stem Cell Research. 17(1). 1–5. 10 indexed citations
7.
Sousa, Paul A. De, et al.. (2016). Derivation of the human embryonic stem cell line RCe012-A (RC-8). Stem Cell Research. 16(2). 489–492. 1 indexed citations
8.
Sousa, Paul A. De, K. Bruce, D.M. Collins, et al.. (2016). Derivation of the clinical grade human embryonic stem cell line RCe020-a (RC-16). Stem Cell Research. 16(3). 790–794. 1 indexed citations
9.
Sousa, Paul A. De, et al.. (2016). Derivation of the human embryonic stem cell line RCe014-A (RC-10). Stem Cell Research. 16(2). 537–540. 1 indexed citations
10.
Sousa, Paul A. De, K. Bruce, D.M. Collins, et al.. (2016). Derivation of the clinical grade human embryonic stem cell line RCe019-A (RC-15). Stem Cell Research. 16(3). 751–755. 1 indexed citations
11.
Sousa, Paul A. De, K. Bruce, D.M. Collins, et al.. (2016). Derivation of the clinical grade human embryonic stem cell line RCe015-A (RC-11). Stem Cell Research. 17(1). 42–48. 4 indexed citations
12.
Sousa, Paul A. De, et al.. (2016). Derivation of the human embryonic stem cell line RCe011-A (RC-7). Stem Cell Research. 16(2). 485–488. 1 indexed citations
13.
Sousa, Paul A. De, K. Bruce, D.M. Collins, et al.. (2016). Derivation of the clinical grade human embryonic stem cell line RCe016-A (RC-12). Stem Cell Research. 16(3). 770–775. 2 indexed citations
14.
Sousa, Paul A. De, Sharon Sneddon, K. Bruce, et al.. (2015). Derivation of the human embryonic stem cell line RCM1. Stem Cell Research. 16(2). 476–480. 2 indexed citations
15.
Sousa, Paul A. De, John O. Gardner, Sharon Sneddon, et al.. (2009). Clinically failed eggs as a source of normal human embryo stem cells. Stem Cell Research. 2(3). 188–197. 20 indexed citations
16.
Collins, D.M., Hannah Murdoch, Allan J. Dunlop, et al.. (2008). Ndel1 alters its conformation by sequestering cAMP-specific phosphodiesterase-4D3 (PDE4D3) in a manner that is dynamically regulated through Protein Kinase A (PKA). Cellular Signalling. 20(12). 2356–2369. 34 indexed citations
17.
Huston, Elaine, Martin J. Lynch, Ahmed Mohamed, et al.. (2008). EPAC and PKA allow cAMP dual control over DNA-PK nuclear translocation. Proceedings of the National Academy of Sciences. 105(35). 12791–12796. 101 indexed citations
18.
Murdoch, Hannah, Shaun Mackie, D.M. Collins, et al.. (2007). Isoform-Selective Susceptibility of DISC1/Phosphodiesterase-4 Complexes to Dissociation by Elevated Intracellular cAMP Levels. Journal of Neuroscience. 27(35). 9513–9524. 125 indexed citations
19.
Mitchell, Rory, Derek N. Robertson, Pamela J. Holland, et al.. (2003). ADP-ribosylation Factor-dependent Phospholipase D Activation by the M3 Muscarinic Receptor. Journal of Biological Chemistry. 278(36). 33818–33830. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026